GlassScriptPhysician profile
Kenneth Carle
NPI 1699790105
$1,729.92
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2021: $136 · 2022: $143 · 2023: $1,314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,156 · Travel and Lodging: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,156.42 |
| Travel and Lodging | $157.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $431.72 | 2022-2023 | Ubrelvy, Qulipta |
| Pacira Pharmaceuticals Incorporated | $373.22 | 2023 | Iovera, Exparel, Zilretta |
| Averitas Pharma INC. | $195.97 | 2023 | Qutenza |
| Horizon Therapeutics Plc | $185.44 | 2021-2022 | |
| Tactile Systems Technology INC | $107.78 | 2019 | |
| Boston Scientific Corporation | $91.84 | 2022-2023 | Infinion 16 |
| Medtronic, INC. | $89.81 | 2023 | Intellis Adaptivestim |
| Collegium Pharmaceutical, INC. | $63.25 | 2023 | Xtampza |
| Orexo US, INC. | $38.86 | 2023 | Zubsolv |
| Pfizer INC. | $36.79 | 2023 | |
| Almatica Pharma LLC | $35.26 | 2022-2023 | Gralise |
| Sentynl Therapeutics, INC. | $28.70 | 2019 | |
| Scilex Pharmaceuticals INC. | $21.42 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.01 | 2022 | |
| Curonix LLC | $13.85 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Carle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.